Results

Total Results: 296 records

Showing results for "hepatitis c".
Users also searched for: hepatitis c

21. Health Equity | Agency for Healthcare Research and Quality
    www.ahrq.gov/ncepcr/reports/2024-annual-report/recent-grants-health-equity.html
    May 01, 2024 - Appendix C: Additional Tables by Topic Area 8. … Mixed-Methods Evaluation of the Uptake of New Direct  Acting Antiviral Regimens for the Treatment of Hepatitis … C Virus (R01) PI: Karen M Clements Organization: University of Massachusetts Medical School, Worcester … analyses to examine uptake of newer and more effective direct-acting antiviral (DAA) treatment for hepatitis … C virus among Medicaid populations across multiple states.

22. AHRQ Works: Building Bridges Between Research and Practice | Agency for Healthcare Research and Quality
    www.ahrq.gov/cpi/about/impact/index.html
    April 01, 2017 - at an urban academic medical center and rural primary care physicians to combat widespread untreated hepatitis … C in New Mexico. … pain and opioid management and the Veterans Health Administration for diabetes, pain management, and hepatitis … C.

23. Statin Therapy Measure Narative (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/cholesterol-narrative.pdf
    December 31, 2018 - OR adult patients aged >=21 years with a fasting or direct Low-Density Lipoprotein Cholesterol (LDL-C) … 190 mg/dL; OR patients aged 40-75 years with a diagnosis of diabetes with a fasting or direct LDL-C … Vascular Disease, Hemorrhagic Stroke, Ischemic Stroke, CABG Surgeries, Carotid Intervention); • LDL-C … measurement period with an active diagnosis of diabetes (Diabetes Value Set) with the highest LDL-C … • Patients with end stage renal disease (End Stage Renal Disease Care Value Set) • Most recent LDL-C

24. AHRQ Works: Building Bridges Between Research and Practice (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/cpi/about/impact/ahrq-works.pdf
    April 01, 2017 - an urban academic medical center and rural primary care physicians to combat widespread untreated hepatitis … C in New Mexico. … pain and opioid management and the Veterans Health Administration for diabetes, pain management, and hepatitis … C.

25. Appendix P. Focus Group Risk Factors | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/final-reports/ssi/ssiapp.html
    April 01, 2018 - In-Person Meetings Appendix C. Data Dictionary Appendix D.

26. Section 1, Tables 1 and 2 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
    June 02, 2025 - criteria, one of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C … of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C or < 36°C … < 0.5 mL/kg/hr – Prolonged capillary refill: > 5 seconds – Core to peripheral temperature gap > 3°C

27. Section 1, Tables 1 and 2 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
    June 02, 2025 - criteria, one of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C … which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C or < 36°C … < 0.5 mL/kg/hr – Prolonged capillary refill: > 5 seconds – Core to peripheral temperature gap > 3°C

28. Section 1, Tables 1 and 2 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
    June 02, 2025 - criteria, one of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C … of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C or < 36°C … < 0.5 mL/kg/hr – Prolonged capillary refill: > 5 seconds – Core to peripheral temperature gap > 3°C

29. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
    www.ahrq.gov/policymakers/chipra/overview/background/appendix-a1.html
    December 01, 2009 - for Medicaid and State Operations CPT Current Procedural Terminology (coding scheme) C-section … information technology HEDIS Healthcare Effectiveness Data and Information Set Hep B Hepatitis

30. Appendix A. Literature Review | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/final-reports/stpra/stpraapa.html
    April 01, 2018 - Database Analysis Appendix C. Site Visit Protocol Appendix D. … For example, in 2008, the largest outbreak of HAIs caused by the Hepatitis C virus was reported, and … This represents the largest Hepatitis C virus outbreak in the US history, with an estimated number of … Maintenance of normothermia (temperature more than 36.0 °C) during the perioperative period. … C virus (HCV) infection, hepatitis B virus (HBV) infection, presence of lipodistrophy, HIV viral load

31. Section 1, Tables 1 to 3 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-1-tables-1-3.pdf
    June 02, 2025 - criteria, one of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C … of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C or < 36°C … < 0.5 mL/kg/hr – Prolonged capillary refill: > 5 seconds – Core to peripheral temperature gap > 3°C

32. Children with Disabilities Algorithm (CWDA) A Claims-Based Tool for Identifying Children with Disabilities (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-section-2.pdf
    January 01, 2020 - : Instructions for Use ................................................................ 3 SAS C … \Users\Desktop"; /*2*/ libname OUT "C:\Users\Desktop"; /*3*/ %let indata=OTIP2008_AGE1_18 … NEC 0469 Cns slow virus infec NOS Other Diseases Due To Viruses And Chlamydiae (070-079) 0700 Hepatitis … acute w hepat Coma 07042 Hpt dlt wo b w hpt coma 07043 Hpt E w hepat Coma 07044 Chrnc hpt C w … Barrett, BA Sarabeth Broder-Fingert, MD Maria C. Bryant, BA Michael J.

33. Adaptation of AHRQ Patient Safety Indicators for Use in ICD-10 Administrative Data by an International Consortium (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Quan_52.pdf
    March 10, 2008 - A with hepatic coma), 070.2 (viral hepatitis B with hepatic coma), 070.4x (other specified viral hepatitis … with hepatic coma), 070.6 (unspecified viral hepatitis with hepatic coma), 070.71 (unspecified viral … hepatitis C with hepatic coma), and 780.09 (other drowsiness, semicoma, unconsciousness, somnolence … De Coster C, Quan H, Finlayson A, et al. … Zhan C, Miller MR.

34. Study Identifies Trends in Attention Deficit Hyperactivity Disorder Medication Misuse | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsletters/e-newsletter/969.html
    August 01, 2025 - Initial real-world pilot of the MedMorph reference architecture: hepatitis C surveillance and research … Antunez AG, Kazemi RJ, Richburg C, et al. JAMA Surg 2025 Mar;160(3):304-11.

35. Sepsis in the ED Detailed Measure, Technical Specifications (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-detailed_measure-specs.pdf
    August 01, 2014 - criteria, one of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C … of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C or < 36°C … < 0.5 mL/kg/hr – Prolonged capillary refill: > 5 seconds – Core to peripheral temperature gap > 3°C

36. Statin Therapy Measure Flow Chart (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/cholesterol-flowchart.pdf
    June 02, 2025 - REMOVED FROM DENOMINATOR No PATIENT NOT INCLUDED IN NUMERATOR 1 No Did the patient have a LDL-C … Yes PATIENT INCLUDED IN NUMERATOR 3 No Was the patient’s highest LDL-C result during the measurement

37. Section 1, Tables 1-4 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
    June 02, 2025 - criteria, one of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C … of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C or < 36°C … < 0.5 mL/kg/hr – Prolonged capillary refill: > 5 seconds – Core to peripheral temperature gap > 3°C

38. Section 2, Technical Specifications (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-2-tech-specs.pdf
    June 02, 2025 - criteria, one of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C … of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C or < 36°C … < 0.5 mL/kg/hr – Prolonged capillary refill: > 5 seconds – Core to peripheral temperature gap > 3°C

39. Chapter-7 - Harm Due to Anticoagulants (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
    March 01, 2020 - Harris Y, Hu DJ, Lee C, et al. … An J, Niu F, Zheng C, et al. … Harris Y, Hu DJ, Lee C, et al. … Harris Y, Hu DJ, Lee C, et al. … Barbic D, DeWitt C, Harris D, et al.

40. Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
    August 01, 2014 - Antibiotics must be in one of the classes listed in Table 4-C. … criteria, one of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C … of which must be abnormal temperature or leukocyte count: • Core temperature of > 38.5°C or < 36°C … < 0.5 mL/kg/hr – Prolonged capillary refill: > 5 seconds – Core to peripheral temperature gap > 3°C … non-infectious process with acute organ dysfunction 995.94 Bacteremia 790.7 Septic shock 785.52 Table 4-C: